Abstract
A child with a ganglioneuroblastoma and tumor uptake of99mtechnetium methylene diphosphonate (99mTc-MDP) is presented. After surgical removal of an encapsulated tumor and radiation therapy, an interval bone scan demonstrated the same presurgical abnormality. Awareness of abnormal uptake of99mTc-MDP in irradiated renal tissue prevents interpreting radiation nephritis as recurrent tumor.
References
Blaufox, M. D., Freeman, L. M.: Benign bone disorders. Semin. Nucl. Med.6 (1976)
Gilday, D. L., Ash, J. M., Reilly, B. J.: Radionuclide skeletal survey for pediatric neoplasms. Radiology123, 399 (1977)
Koenigsberg, M., Freeman, L. M.: Radionuclide bone imaging. Curr. Probl. Diagn. Radiol.6 (1976)
Sty, J. R., Babbitt, D. P., Kun, L.:99mTc-MDP renal imaging in pediatric oncology. Clin. Nucl. Med.4, 36 (1979)
Sty, J. E., Babbitt, D. P., Casper, J.:99mTc-MDP imaging in neural crest tumors. Clin. Nucl. Med.4, 12 (1979)
Wistow, B. W., MaAfee, J. G., Sagerman, R. H., et al.: Renal uptake of Tc-99m methylene diphosphonate after radiation therapy. J. Nucl. Med.20, 32 (1979)
Young, G., L'Heureux, P.: Extraosseous tumor uptake of99mtechnetium phosphate compounds in children with abdominal neuroblastoma. Pediatr. Radiol7, 159 (1978)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sty, J.R., Kun, L., Casper, J. et al. Extraosseous uptake of99mtechnetium methylene diphosphonate: Neuroblastoma or radiation therapy. Pediatr Radiol 9, 53–54 (1980). https://doi.org/10.1007/BF00973974
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00973974